APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Live Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Live Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174008410322 December 2025185 pages

Choose your research edition.

Industry ResearchLive Vaccines Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Vaccines Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Live Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Live Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Live Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Live Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Live Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Live Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Live Vaccines include Astellas Pharma, Emergent BioSolutions, AstraZeneca, GlaxoSmithKline, Pfizer, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Live Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Live Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Live Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Live Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Live Vaccines Segment by Company

Astellas Pharma

Emergent BioSolutions

AstraZeneca

GlaxoSmithKline

Pfizer

Merck

Novartis

Live Vaccines Segment by Type

Monovalent Live Vaccines

Multivalent Live Vaccines

Live Vaccines Segment by Application

Adults

Children

Live Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Live Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Live Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Live Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Live Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Live Vaccines Industry Trends Table 2. Live Vaccines Industry Drivers Table 3. Live Vaccines Industry Opportunities and Challenges Table 4. Live Vaccines Industry Restraints Table 5. Global Live Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Live Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Live Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Live Vaccines Sales Market Share by Manufacturers Table 9. Global Live Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Live Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Live Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Live Vaccines Manufacturers, Product Type & Application Table 13. Global Live Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Live Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monovalent Live Vaccines Table 17. Major Manufacturers of Multivalent Live Vaccines Table 18. Global Live Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Live Vaccines Sales by Type (2021-2026) & (k units) Table 20. Global Live Vaccines Sales by Type (2027-2032) & (k units) Table 21. Global Live Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Live Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Live Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Live Vaccines Revenue by Type (2021-2026) & (k units) Table 25. Global Live Vaccines Revenue by Type (2027-2032) & (k units) Table 26. Global Live Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Live Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adults Table 29. Major Manufacturers of Children Table 30. Global Live Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Live Vaccines Sales by Application (2021-2026) & (k units) Table 32. Global Live Vaccines Sales by Application (2027-2032) & (k units) Table 33. Global Live Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Live Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Live Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Live Vaccines Revenue by Application (2021-2026) & (k units) Table 37. Global Live Vaccines Revenue by Application (2027-2032) & (k units) Table 38. Global Live Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Live Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Live Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Live Vaccines Sales by Region (2021-2026) & (k units) Table 42. Global Live Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Live Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Live Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Live Vaccines Sales by Country (2021-2026) & (k units) Table 47. North America Live Vaccines Sales by Country (2027-2032) & (k units) Table 48. Europe Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Live Vaccines Sales by Country (2021-2026) & (k units) Table 50. Europe Live Vaccines Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Live Vaccines Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Live Vaccines Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Live Vaccines Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Live Vaccines Sales by Country (2027-2032) & (k units) Table 57. Global Live Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Live Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Live Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Live Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Live Vaccines Revenue Market Share by Region (2027-2032) Table 62. Astellas Pharma Company Information Table 63. Astellas Pharma Business Overview Table 64. Astellas Pharma Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Astellas Pharma Live Vaccines Product Portfolio Table 66. Astellas Pharma Recent Development Table 67. Emergent BioSolutions Company Information Table 68. Emergent BioSolutions Business Overview Table 69. Emergent BioSolutions Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Emergent BioSolutions Live Vaccines Product Portfolio Table 71. Emergent BioSolutions Recent Development Table 72. AstraZeneca Company Information Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. AstraZeneca Live Vaccines Product Portfolio Table 76. AstraZeneca Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Live Vaccines Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Live Vaccines Product Portfolio Table 86. Pfizer Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Merck Live Vaccines Product Portfolio Table 91. Merck Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Live Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Novartis Live Vaccines Product Portfolio Table 96. Novartis Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Live Vaccines Distributors List Table 100. Live Vaccines Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Live Vaccines Product Image Figure 2. Global Live Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Live Vaccines Sales (2021-2032) & (k units) Figure 5. Global Live Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Live Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monovalent Live Vaccines Image Figure 9. Multivalent Live Vaccines Image Figure 10. Global Live Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Live Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Live Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Live Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Live Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Live Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Adults Image Figure 17. Children Image Figure 18. Global Live Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Live Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Live Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Live Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Live Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Live Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Live Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Live Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Live Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Live Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Live Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Live Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Live Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Live Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Live Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Live Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Live Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Live Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Live Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Live Vaccines
  • Multivalent Live Vaccines
Applications
  • Adults
  • Children
Companies covered
  • Astellas Pharma
  • Emergent BioSolutions
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Live Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Live Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Live Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Live Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Live Vaccines Market Dynamics
  1. 2.1 Live Vaccines Industry Trends
  2. 2.2 Live Vaccines Industry Drivers
  3. 2.3 Live Vaccines Industry Opportunities and Challenges
  4. 2.4 Live Vaccines Industry Restraints
3 Live Vaccines Market by Manufacturers
  1. 3.1 Global Live Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Live Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Live Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Live Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Live Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Live Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Live Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Live Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Live Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Live Vaccines Tier 1, Tier 2, and Tier 3
4 Live Vaccines Market by Type
  1. 4.1 Live Vaccines Type Introduction
  2. 4.1.1 Monovalent Live Vaccines
  3. 4.1.2 Multivalent Live Vaccines
  4. 4.2 Global Live Vaccines Sales by Type
  5. 4.2.1 Global Live Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Live Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Live Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Live Vaccines Revenue by Type
  9. 4.3.1 Global Live Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Live Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Live Vaccines Revenue Market Share by Type (2021-2032)
5 Live Vaccines Market by Application
  1. 5.1 Live Vaccines Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Live Vaccines Sales by Application
  5. 5.2.1 Global Live Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Live Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Live Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Live Vaccines Revenue by Application
  9. 5.3.1 Global Live Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Live Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Live Vaccines Revenue Market Share by Application (2021-2032)
6 Global Live Vaccines Sales by Region
  1. 6.1 Global Live Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Live Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Live Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Live Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Live Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Live Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Live Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Live Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Live Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Live Vaccines Revenue by Region
  1. 7.1 Global Live Vaccines Revenue by Region
  2. 7.1.1 Global Live Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Live Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Live Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Live Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Live Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Live Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Live Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Live Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Live Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas Pharma
  2. 8.1.1 Astellas Pharma Company Information
  3. 8.1.2 Astellas Pharma Business Overview
  4. 8.1.3 Astellas Pharma Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astellas Pharma Live Vaccines Product Portfolio
  6. 8.1.5 Astellas Pharma Recent Developments
  7. 8.2 Emergent BioSolutions
  8. 8.2.1 Emergent BioSolutions Company Information
  9. 8.2.2 Emergent BioSolutions Business Overview
  10. 8.2.3 Emergent BioSolutions Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Emergent BioSolutions Live Vaccines Product Portfolio
  12. 8.2.5 Emergent BioSolutions Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Live Vaccines Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Live Vaccines Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Live Vaccines Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Live Vaccines Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Live Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Live Vaccines Product Portfolio
  42. 8.7.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Live Vaccines Value Chain Analysis
  2. 9.1.1 Live Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Live Vaccines Production Mode & Process
  6. 9.2 Live Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Live Vaccines Distributors
  9. 9.2.3 Live Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst